The Affiliated Nanjing Drum Tower Hospital Of Nanjing University Medical School
Clinical trials sponsored by The Affiliated Nanjing Drum Tower Hospital Of Nanjing University Medical School, explained in plain language.
-
New pill shows promise for controlling stubborn high blood pressure
Disease control CompletedThis study tested a new drug called finerenone in 55 adults with primary aldosteronism, a condition where a hormone imbalance causes high blood pressure. The goal was to see if finerenone can safely lower blood pressure over 12 weeks. Participants had high blood pressure despite …
Phase: PHASE4 • Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Disease control
Last updated May 26, 2026 03:03 UTC
-
Timing of Weight-Loss drug after surgery studied
Disease control CompletedThis study looked at 100 people who were still obese 6 months after weight-loss surgery. Researchers wanted to see if starting the drug liraglutide early helps with more weight loss. The goal is to find the best time to add this medication for better results.
Phase: PHASE4 • Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Disease control
Last updated May 26, 2026 02:48 UTC
-
10,000 seniors studied to predict fatty liver dangers
Knowledge-focused CompletedThis study looked at health records from 10,000 people aged 60 and older with fatty liver disease. The goal was to find out which factors increase the risk of serious liver problems like scarring, cirrhosis, or liver cancer. Researchers used computer models to predict these risks…
Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Knowledge-focused
Last updated May 22, 2026 13:52 UTC